Kapitalo Investimentos Ltda Gilead Sciences, Inc. Transaction History

Kapitalo Investimentos Ltda

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Mar 29, 2024	SELL	$73.27 - $83.09 $204,643 - $232,070	-2,793 Reduced 47.58%	3,077 $249 Million
Q3 2023 Mar 29, 2024	BUY	$73.94 - $80.67 $292,728 - $319,372	3,959 Added 207.17%	5,870 $440 Million
Q2 2023 Mar 29, 2024	SELL	$76.01 - $86.7 $117,055 - $133,518	-1,540 Reduced 44.62%	1,911 $147 Million
Q1 2023 Mar 29, 2024	BUY	$77.31 - $88.08 $266,796 - $303,964	3,451 New	3,451 $286 Million

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Kapitalo Investimentos Ltda, based on Form 13F filings with the SEC.

Stay updated on Kapitalo Investimentos Ltda with notifications on news.